CDMRP Parkinson’s Research Program: Investigator-Initiated Research Award

The PRP IIRA supports highly rigorous, multidisciplinary, high-impact research projects that have the potential to make an important contribution to Parkinson’s research. This award mechanism supports the full spectrum of research from basic science through clinical research.

Applicants MUST address at least one of the following FY26 PRP Focus Areas:

• Understanding how Parkinson’s disease biological and clinical heterogeneity impacts disease presentation, clinical course and therapeutic outcomes, from prodromal to late stage Parkinson’s disease.

• Development and characterization of in vitro model systems that approximate in vivo cellular and system complexity.

• Biological mechanisms or biomarkers, such as clinical, fluid, imaging, tissue, and devices, of unmet medical needs that could lead to the development of treatments for PD.

• Interventions that address unmet medical needs of PD that include both clinical and preclinical models. 

It is expected that 5 awards will be granted. 

Funding: $2,000,000 total

Duration: 3 years 

Research Authority due date: 18.10.26

Pre application (required) due date: 23.10.26

Full proposal due date: 6.11.26